Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 55

Sort by

Sort Order Select

Journal Articles

The Therapeutic Efficacy and Blood Drug Concentration of Posaconazole Enteric-Coated Tablets in Preventing Pulmonary Invasive Fungal Disease after HSCT

Jiaxin Cao, Aiming Pang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 3540.

https://doi.org/10.1182/blood-2023-189180

Published: 2023

Journal Articles

Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in Patients with Hematologic Diseases: A Single-Center Retrospective Study

Jieru Wang, Sisi Zhen, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 2163.

https://doi.org/10.1182/blood-2023-189152

Published: 2023

Journal Articles

The Modified Melphalan-Cladribine-Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo-HSCT in Refractory/Relapsed AML

Xiaoyu Zhang, Shulian Chen, Weihua Zhai, Yi He, Sizhou Feng, Mingzhe Han, Ting Niu, Yajing Xu, Guangxun Gao, Shengjin Fan, Zepin Zhou, Fang Zhou, Rui Xi, Li Liu, Wei Yang, Xi Zhang, Qifa Liu, Erlie Jiang

Blood (2023) 142 (Supplement 1): 474.

https://doi.org/10.1182/blood-2023-184477

Published: 2023

Journal Articles

Comparison of Autologous, Matched Sibling, and Alternative Donor Stem Cell Transplant Outcomes for Acute Myeloid Leukemia Patients in First Remission: A Propensity Score Matching Study

Erlie Jiang, Mingyang Wang

Blood (2023) 142 (Supplement 1): 2849.

https://doi.org/10.1182/blood-2023-181998

Published: 2023

Journal Articles

Recipient Resident Macrophage Plays a Crucial Role in Acute Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation By Regulation of Damage-Associated Molecular Pattern Phagocytosis

Yuyan Shen, Tingting Zhang, Zhangjie Chen, Sisi Zhen, Jieru Wang, Erlie Jiang, Xudong Liao, Sizhou Feng

Blood (2023) 142 (Supplement 1): 4798.

https://doi.org/10.1182/blood-2023-185874

Published: 2023

Journal Articles

Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS

Yigeng Cao, Wenwen Guo, Weihua Zhai, Jialin Wei, Qiaoling MA, Donglin Yang, AiMing Pang, Mingzhe Han, Erlie Jiang

Blood (2023) 142 (Supplement 1): 4952.

https://doi.org/10.1182/blood-2023-180847

Published: 2023

Journal Articles

Comparison of Therapeutic Effects between Young Haploidentical Donors and Elderly HLA-Matched Relative Donors for AML Patients Who Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Conditioning Regime Including ATG

Haixiao Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 7092.

https://doi.org/10.1182/blood-2023-189143

Published: 2023

Journal Articles

Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I)

Runzhi Ma, Sisi Zhen, Li Liu, Jieru Wang, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 7094.

https://doi.org/10.1182/blood-2023-190923

Published: 2023

Journal Articles

Enteral Versus Parenteral Nutrition in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Fucong Peng, Huijuan Zhang, Wenjun Xie, Erlie Jiang

Blood (2023) 142 (Supplement 1): 7088.

https://doi.org/10.1182/blood-2023-185568

Published: 2023

Journal Articles

Is Short-Course Antibiotic Therapy Suitable for Pseudomonas Aeruginosa Bloodstream Infections in Onco-Hematology Patients with Febrile Neutropenia? Results of a Multi-Institutional Analysis

Xiaomeng Feng, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5919.

https://doi.org/10.1182/blood-2023-188177

Published: 2023

Journal Articles

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Xiaofei Ni, Weihua Zhai, AiMing Pang, Donglin Yang, Xin Chen, Qiaoling MA, Jialin Wei, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 6974.

https://doi.org/10.1182/blood-2023-181449

Published: 2023

Journal Articles

Ceftazidime-Avibactam in the Treatment of Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacteria in Hematological Patients: Experience in a Single Center

Sisi Zhen, Qingsong Lin, Weihua Zhai, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5363.

https://doi.org/10.1182/blood-2023-188815

Published: 2023

Journal Articles

Diagnostic Performance and Clinical Impacts of Metagenomic Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation

Chunhui Xu, Xin Chen, Huiming Yi, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 5020.

https://doi.org/10.1182/blood-2023-187950

Published: 2023

Journal Articles

Analysis of Post-Transplant Clinical Outcomes and Prognostic Factors in FLT3-ITD Mutated Acute Myeloid Leukemia Patients Under ELN 2022 Risk Stratification

Chen Liang, Aiming Pang, Yi He, Donglin Yang, Rongli Zhang, Qiaoling MA, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 3619.

https://doi.org/10.1182/blood-2023-184582

Published: 2023

Journal Articles

Combining Low-Dose Post-Transplant Cyclophosphamide(PTCY) with Anti-Thymocyte Globulin(ATG) for Prophylaxis of Graft-Versus-Host Disease in Alternative-Donor Hematopoietic Stem Cell Transplantation for β-Thalassemia Major

Jingyuan Lu, Yanhong Zhuang, Xiuli Hong, Jie Chen, Yanxin Chen, Erlie Jiang, Quanyi Lu

Blood (2023) 142 (Supplement 1): 3568.

https://doi.org/10.1182/blood-2023-186196

Published: 2023

Journal Articles

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Xiaoyu Zhang, Yanhong Zhao, Rongli Zhang, Weihua Zhai, Yi He, Jialin Wei, Donglin Yang, Aiming Pang, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5892.

https://doi.org/10.1182/blood-2023-184400

Published: 2023

Journal Articles

Effect of Ursodeoxycholic Acid for Sars-Cov-2 Prevention in Hematological Malignancies: An Observational Real-World Study

Hongye Gao, Jiali Wang, Xinhui Zheng, Yigeng Cao, Erlie Jiang

Blood (2023) 142 (Supplement 1): 7308.

https://doi.org/10.1182/blood-2023-182862

Published: 2023

Journal Articles

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

Yanhong Zhao, Weihua Zhai, Aiming Pang, Donglin Yang, Yi He, Jialin Wei, Qiaoling MA, Xin Chen, Mingzhe Han, Sizhou Feng, Rongli Zhang, Erlie Jiang

Blood (2023) 142 (Supplement 1): 5893.

https://doi.org/10.1182/blood-2023-184565

Published: 2023

Journal Articles

Recombinant Human Thrombopoietin Reduces the Risk of Acute Graft-Versus-Host-Disease and Its Mechanisms

Fei Rong, Chunting Zhao, Xiaodan Liu, Xiaolin Ma, Erlie Jiang, Sizhou Feng

Blood (2023) 142 (Supplement 1): 6962.

https://doi.org/10.1182/blood-2023-188903

Published: 2023

Journal Articles

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Weihua Zhai, Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Ying Wang, Erlie Jiang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 7073.

https://doi.org/10.1182/blood-2023-180077

Published: 2023

NARROW

The Therapeutic Efficacy and Blood Drug Concentration of Posaconazole Enteric-Coated Tablets in Preventing Pulmonary Invasive Fungal Disease after HSCT

Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in Patients with Hematologic Diseases: A Single-Center Retrospective Study

The Modified Melphalan-Cladribine-Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo-HSCT in Refractory/Relapsed AML

Comparison of Autologous, Matched Sibling, and Alternative Donor Stem Cell Transplant Outcomes for Acute Myeloid Leukemia Patients in First Remission: A Propensity Score Matching Study

Recipient Resident Macrophage Plays a Crucial Role in Acute Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation By Regulation of Damage-Associated Molecular Pattern Phagocytosis

Venetoclax Plus Azacitidine Versus Azacitidine Alone As Post-Transplant Maintenance Treatment in High-Risk AML and MDS

Comparison of Therapeutic Effects between Young Haploidentical Donors and Elderly HLA-Matched Relative Donors for AML Patients Who Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Conditioning Regime Including ATG

Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I)

Enteral Versus Parenteral Nutrition in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis

Is Short-Course Antibiotic Therapy Suitable for Pseudomonas Aeruginosa Bloodstream Infections in Onco-Hematology Patients with Febrile Neutropenia? Results of a Multi-Institutional Analysis

A Modified Busulfan/Cyclophosphamide Preconditioning Regimen Incorporating Selinexor for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hematologic Malignancies

Ceftazidime-Avibactam in the Treatment of Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacteria in Hematological Patients: Experience in a Single Center

Diagnostic Performance and Clinical Impacts of Metagenomic Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation

Analysis of Post-Transplant Clinical Outcomes and Prognostic Factors in FLT3-ITD Mutated Acute Myeloid Leukemia Patients Under ELN 2022 Risk Stratification

Combining Low-Dose Post-Transplant Cyclophosphamide(PTCY) with Anti-Thymocyte Globulin(ATG) for Prophylaxis of Graft-Versus-Host Disease in Alternative-Donor Hematopoietic Stem Cell Transplantation for β-Thalassemia Major

The Efficacy and Safety of the Third Generation TKI Olverembatinib in Adult Ph+ Acute Lymphoblastic Leukemia with Relapsed Disease or Persistent MRD Bridging to Allo-HSCT: A Case Series from a Single Center

Effect of Ursodeoxycholic Acid for Sars-Cov-2 Prevention in Hematological Malignancies: An Observational Real-World Study

Efficacy and Safety of Olverembatinib-Based Therapies in Patients with Ph/BCR-ABL1-Positive Acute Lymphoblastic Leukemia

Recombinant Human Thrombopoietin Reduces the Risk of Acute Graft-Versus-Host-Disease and Its Mechanisms

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only